1 | Study | 2.17% | |
2 | Finds | 1.3% | |
3 | Patients | 1.3% | |
4 | Report | 1.3% | |
5 | Therapy | 0.87% | |
6 | Cancer | 0.87% | |
7 | New | 0.87% | |
8 | Development | 0.87% | |
9 | Childhood | 0.87% | |
10 | Clinical | 0.87% | |
11 | May | 0.87% | |
12 | Case | 0.87% | |
13 | Blood | 0.87% | |
14 | Slow | 0.87% | |
15 | Disease | 0.87% | |
16 | Norovirus | 0.43% | |
17 | AstriVax | 0.43% | |
18 | HIV-1 | 0.43% | |
19 | Side | 0.43% | |
20 | Bronchiolitis | 0.43% | |
21 | Glaucoma | 0.43% | |
22 | Gut | 0.43% | |
23 | Parkinsons | 0.43% | |
24 | Breakfasts | 0.43% | |
25 | Loss | 0.43% | |
26 | Improved | 0.43% | |
27 | Federal | 0.43% | |
28 | Hyponatremia | 0.43% | |
29 | Vaccine | 0.43% | |
30 | Menopause | 0.43% | |
31 | CABG | 0.43% | |
32 | Immunity | 0.43% | |
33 | Viral | 0.43% | |
34 | Spread | 0.43% | |
35 | Antibody | 0.43% | |
36 | ADHD | 0.43% | |
37 | Drug | 0.43% | |
38 | Sabah | 0.43% | |
39 | Inhibitor | 0.43% | |
40 | Nirsevimab | 0.43% | |
41 | Expands | 0.43% | |
42 | Receptivity | 0.43% | |
43 | Randomized | 0.43% | |
44 | Collagen | 0.43% | |
45 | GII.17 | 0.43% | |
46 | Accelerated | 0.43% | |
47 | Reefs | 0.43% | |
48 | Wilms | 0.43% | |
49 | CRAIC | 0.43% | |
50 | Preexisting | 0.43% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|